Form 4: Guardant Health CFO Michael Bell Reports Routine RSU Vesting and Tax Withholding

Guardant Health, Inc.'s Chief Financial Officer, Michael Brian Bell, reported the vesting of restricted stock units and the subsequent disposition of shares to cover tax obligations.

Summary

• Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc. (GH), reported changes in his beneficial ownership of company common stock.
• On July 1, 2025, Mr. Bell acquired 2,084 shares of common stock through the exercise/conversion of derivative securities (Restricted Stock Units) at a price of $0.
• Concurrently, 1,057 shares of common stock were disposed of at a price of $50.71 per share to satisfy tax withholding obligations related to the vesting of the restricted stock units.
• The shares disposed for tax purposes did not exceed the amount of the tax liability.
• Following these transactions, Mr. Bell's direct beneficial ownership of common stock is 43,028 shares.
• He also holds 10,421 Restricted Stock Units directly.
• The Restricted Stock Unit award was granted on December 13, 2023, with 33% vesting on October 1, 2024, and the remaining 67% vesting in equal quarterly installments over the subsequent two-year period.

Sentiment

Score: 5

Explanation: The sentiment is neutral. This is a routine insider transaction (vesting of RSUs and tax withholding) and does not indicate any discretionary buying or selling by the executive that would suggest a positive or negative outlook on the company's prospects.

Positives

• The vesting of Restricted Stock Units represents a scheduled compensation event for the Chief Financial Officer, indicating continued alignment of executive incentives with shareholder interests.
• The acquisition of 2,084 common shares at a $0 cost basis reflects the realization of value from previously granted equity awards.

Negatives

• The disposition of 1,057 shares was solely for tax withholding purposes, which is a standard procedure for RSU vesting and does not represent a discretionary sale by the executive.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's financial performance or strategic direction. It solely reports an insider's equity transaction.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation. Such filings are common across all publicly traded companies and reflect standard practices for executive compensation and tax management, rather than broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The transaction is a routine compensation event and tax management, with minimal direct impact on the company's operations or strategic direction. It reflects the ongoing equity compensation structure for executives.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The remaining 67% of the Restricted Stock Unit award will continue to vest in equal quarterly installments over the two-year period following October 1, 2024.

Key Dates

Keywords

Guardant Health, GH, Form 4, insider transaction, Restricted Stock Units, RSU vesting, Michael Brian Bell, Chief Financial Officer, equity compensation, tax withholding